메뉴 건너뛰기




Volumn 12, Issue 10, 2013, Pages 1981-1993

A urokinase receptor-derived peptide inhibiting VEGF-dependent directional migration and vascular sprouting

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYLGLUTAMYLARGINYLPHENYLALANINE; F ACTIN; FOCAL ADHESION KINASE; PROTEIN KINASE B; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; UROKINASE RECEPTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; VITRONECTIN RECEPTOR;

EID: 84885640117     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-13-0077     Document Type: Article
Times cited : (26)

References (45)
  • 1
    • 0034648765 scopus 로고    scopus 로고
    • Angiogenesis in cancer and other diseases
    • Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407: 249-57.
    • (2000) Nature , vol.407 , pp. 249-257
    • Carmeliet, P.1    Jain, R.K.2
  • 2
    • 35548936833 scopus 로고    scopus 로고
    • Models, mechanisms and clinical evidence for cancer dormancy
    • Aguirre-Ghiso JA. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 2007;7: 834-46.
    • (2007) Nat Rev Cancer , vol.7 , pp. 834-846
    • Aguirre-Ghiso, J.A.1
  • 3
    • 85013312416 scopus 로고
    • Tumor angiogenesis: Therapeutic implications
    • Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285: 1182-6.
    • (1971) N Engl J Med , vol.285 , pp. 1182-1186
    • Folkman, J.1
  • 4
    • 30744449235 scopus 로고    scopus 로고
    • Angiogenesis as a therapeutic target
    • Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature 2005;438: 967-74.
    • (2005) Nature , vol.438 , pp. 967-974
    • Ferrara, N.1    Kerbel, R.S.2
  • 5
    • 79953244361 scopus 로고    scopus 로고
    • Antiangiogenic therapy: Impact on invasion, disease progression, and metastasis
    • Ebon JM, Kerbel RS. Antiangiogenic therapy: impact on invasion, disease progression, and metastasis. Nat Rev Clin Oncol 2011;8: 210-21.
    • (2011) Nat Rev Clin Oncol , vol.8 , pp. 210-221
    • Ebon, J.M.1    Kerbel, R.S.2
  • 7
    • 34147171490 scopus 로고    scopus 로고
    • Endothelial cell migration during angiogenesis
    • Lamalice L, Le Boeuf F, Huot J. Endothelial cell migration during angiogenesis. Circ Res 2007;100: 782-94.
    • (2007) Circ Res , vol.100 , pp. 782-794
    • Lamalice, L.1    Le Boeuf, F.2    Huot, J.3
  • 9
    • 0028362876 scopus 로고
    • Requirement of vascular integrin alpha v beta 3 for angiogenesis
    • Brooks PC, Clark RA, Cheresh DA: Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 1994;264: 569-71.
    • (1994) Science , vol.264 , pp. 569-571
    • Brooks, P.C.1    Clark, R.A.2    Cheresh, D.A.3
  • 10
    • 84859075784 scopus 로고    scopus 로고
    • VEGF-induced endothelial cell migration requires urokinase receptor (uPAR)-dependent integrin redistribution
    • Alexander RA, Prager GW, Mihaly-Bison J, Uhrin P, Sunzenauer S, Binder BR, et al. VEGF-induced endothelial cell migration requires urokinase receptor (uPAR)-dependent integrin redistribution. Cardiovasc Res 2012;94: 125-35.
    • (2012) Cardiovasc Res , vol.94 , pp. 125-135
    • Alexander, R.A.1    Prager, G.W.2    Mihaly-Bison, J.3    Uhrin, P.4    Sunzenauer, S.5    Binder, B.R.6
  • 11
    • 0026063532 scopus 로고
    • Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol
    • Ploug M, Rønne E, Behrendt N, Jensen AL, Blasi F, Danø K. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. J Biol Chem 1991;266: 1926-33.
    • (1991) J Biol Chem , vol.266 , pp. 1926-1933
    • Ploug, M.1    Rønne, E.2    Behrendt, N.3    Jensen, A.L.4    Blasi, F.5    Danø, K.6
  • 13
    • 0036906177 scopus 로고    scopus 로고
    • UPAR: A versatile signaling orchestrator
    • Blasi F, Carmeliet P. uPAR: a versatile signaling orchestrator. Nat Rev Mol Cell Biol 2002;3: 932-43.
    • (2002) Nat Rev Mol Cell Biol , vol.3 , pp. 932-943
    • Blasi, F.1    Carmeliet, P.2
  • 14
    • 0038364216 scopus 로고    scopus 로고
    • The urokinase plasminogen activator system in cancer: Recent advances and implication for prognosis and therapy
    • Sidenius N, Blasi F. The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy. Cancer Metastasis Rev 2003;22: 205-22.
    • (2003) Cancer Metastasis Rev , vol.22 , pp. 205-222
    • Sidenius, N.1    Blasi, F.2
  • 15
    • 33846978442 scopus 로고    scopus 로고
    • Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis
    • Shariat SF, Roehrborn CG, McConnell JD, Park S, Alam N, Wheeler TM, et al. Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis. J Clin Oncol 2007;25: 349-55.
    • (2007) J Clin Oncol , vol.25 , pp. 349-355
    • Shariat, S.F.1    Roehrborn, C.G.2    McConnell, J.D.3    Park, S.4    Alam, N.5    Wheeler, T.M.6
  • 16
    • 53249103673 scopus 로고    scopus 로고
    • Cleaved forms of the urokinase plasminogen activator receptor in plasma have diagnostic potential and predict postoperative survival in patients with ovarian cancer
    • Henic E, Borgfeldt C, Christensen IJ, Casslén B, Høyer-Hansen G. Cleaved forms of the urokinase plasminogen activator receptor in plasma have diagnostic potential and predict postoperative survival in patients with ovarian cancer. Clin Cancer Res 2008;14: 5785-93.
    • (2008) Clin Cancer Res , vol.14 , pp. 5785-5793
    • Henic, E.1    Borgfeldt, C.2    Christensen, I.J.3    Casslén, B.4    Høyer-Hansen, G.5
  • 17
    • 52049092484 scopus 로고    scopus 로고
    • Intact and cleaved uPAR forms: Diagnostic and prognostic value in cancer
    • Rasch MG, Lund IK, Almasi CE, Hoyer-Hansen G. Intact and cleaved uPAR forms: diagnostic and prognostic value in cancer. Front Biosci 2008;13: 6752-62.
    • (2008) Front Biosci , vol.13 , pp. 6752-6762
    • Rasch, M.G.1    Lund, I.K.2    Almasi, C.E.3    Hoyer-Hansen, G.4
  • 18
    • 33947321575 scopus 로고    scopus 로고
    • UPAR-uPA-PAI-1 interactions and signaling: A vascular biologist's view
    • Binder BR, Mihaly J, Prager GW. uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view. Thromb Haemost 2007;97: 336-42.
    • (2007) Thromb Haemost , vol.97 , pp. 336-342
    • Binder, B.R.1    Mihaly, J.2    Prager, G.W.3
  • 19
    • 0035721955 scopus 로고    scopus 로고
    • Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis
    • Pepper MS. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 2001;21: 1104-17.
    • (2001) Arterioscler Thromb Vasc Biol , vol.21 , pp. 1104-1117
    • Pepper, M.S.1
  • 20
    • 78650006378 scopus 로고    scopus 로고
    • The soluble form of urokinase receptor promotes angiogenesis through its Ser88-Arg-Ser-Arg-Tyr92 chemotactic sequence
    • Bifulco K, Longanesi-Cattani I, Gala M, DI Carluccio G, Masucci MT, Pavone V, et al. The soluble form of urokinase receptor promotes angiogenesis through its Ser88-Arg-Ser-Arg-Tyr92 chemotactic sequence. J Thromb Haemost 2010;8: 2789-99.
    • (2010) J Thromb Haemost , vol.8 , pp. 2789-2799
    • Bifulco, K.1    Longanesi-Cattani, I.2    Gala, M.3    Carluccio G, D.I.4    Masucci, M.T.5    Pavone, V.6
  • 21
    • 0037022391 scopus 로고    scopus 로고
    • The fibrinolytic receptor for urokinase activates the G proteincoupled chemotactic receptor FPRL1/LXA4R
    • Resnati M, Pallavicini I, Wang JM, Oppenheim J, Serhan CN, Romano M, et al. The fibrinolytic receptor for urokinase activates the G proteincoupled chemotactic receptor FPRL1/LXA4R. Proc Natl Acad Sci USA 2002;99: 1359-64.
    • (2002) Proc Natl Acad Sci USA , vol.99 , pp. 1359-1364
    • Resnati, M.1    Pallavicini, I.2    Wang, J.M.3    Oppenheim, J.4    Serhan, C.N.5    Romano, M.6
  • 22
    • 21644472064 scopus 로고    scopus 로고
    • Cross-talk between fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide
    • Gargiulo L, Longanesi-Cattani I, Bifulco K, Franco P, Raiola R, Campiglia P, et al. Cross-talk between fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide. J Biol Chem 2005;280: 25225-32.
    • (2005) J Biol Chem , vol.280 , pp. 25225-25232
    • Gargiulo, L.1    Longanesi-Cattani, I.2    Bifulco, K.3    Franco, P.4    Raiola, R.5    Campiglia, P.6
  • 23
    • 84866708012 scopus 로고    scopus 로고
    • Single amino acid substitutions in the chemotactic sequence of urokinase receptor modulate cell migration and invasion
    • Bifulco K, Longanesi-Cattani I, Franco P, Pavone V, Mugione P, Di Carluccio G, et al. Single amino acid substitutions in the chemotactic sequence of urokinase receptor modulate cell migration and invasion. PLoS One 2012;7:e44806.
    • (2012) PLoS One , vol.7
    • Bifulco, K.1    Longanesi-Cattani, I.2    Franco, P.3    Pavone, V.4    Mugione, P.5    Di Carluccio, G.6
  • 24
    • 40849140607 scopus 로고    scopus 로고
    • An urokinase receptor antagonist that inhibits cell migration by blocking the formyl peptide receptor
    • Bifulco K, Longanesi-Cattani I, Gargiulo L, Maglio O, Cataldi M, De Rosa M, et al. An urokinase receptor antagonist that inhibits cell migration by blocking the formyl peptide receptor. FEBS Lett 2008;582: 1141-6.
    • (2008) FEBS Lett , vol.582 , pp. 1141-1146
    • Bifulco, K.1    Longanesi-Cattani, I.2    Gargiulo, L.3    Maglio, O.4    Cataldi, M.5    De Rosa, M.6
  • 25
    • 70349484458 scopus 로고    scopus 로고
    • Structure-based design of an urokinase-type plasminogen activator receptor-derived peptide inhibiting cell migration and lung metastasis
    • Carriero MV, Longanesi-Cattani I, Bifulco K, Maglio O, Lista L, Barbieri A, et al. Structure-based design of an urokinase-type plasminogen activator receptor-derived peptide inhibiting cell migration and lung metastasis. Mol Cancer Ther 2009;8: 2708-17.
    • (2009) Mol Cancer Ther , vol.8 , pp. 2708-2717
    • Carriero, M.V.1    Longanesi-Cattani, I.2    Bifulco, K.3    Maglio, O.4    Lista, L.5    Barbieri, A.6
  • 26
    • 77949439845 scopus 로고    scopus 로고
    • In vitro angiogenesis: Endothelial cell tube formation on gelled basement membrane extract
    • Arnaoutova I, Kleinman HK. In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract. Nat Protoc 2010; 5: 628-35.
    • (2010) Nat Protoc , vol.5 , pp. 628-635
    • Arnaoutova, I.1    Kleinman, H.K.2
  • 27
    • 0025835870 scopus 로고
    • A soluble, ligand binding mutant of the human urokinase plasminogen activator receptor
    • Masucci MT, Pedersen N, Blasi F. A soluble, ligand binding mutant of the human urokinase plasminogen activator receptor. J Biol Chem 1991;266: 8655-8.
    • (1991) J Biol Chem , vol.266 , pp. 8655-8658
    • Masucci, M.T.1    Pedersen, N.2    Blasi, F.3
  • 28
    • 0028090482 scopus 로고
    • Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies
    • Carriero MV, Franco P, Del Vecchio S, Massa O, Botti G, D'Aiuto G, et al. Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies. Cancer Res 1994;54: 5445-54.
    • (1994) Cancer Res , vol.54 , pp. 5445-5454
    • Carriero, M.V.1    Franco, P.2    Del Vecchio, S.3    Massa, O.4    Botti, G.5    D'Aiuto, G.6
  • 29
    • 0031454617 scopus 로고    scopus 로고
    • Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
    • O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997;88: 277-85.
    • (1997) Cell , vol.88 , pp. 277-285
    • O'Reilly, M.S.1    Boehm, T.2    Shing, Y.3    Fukai, N.4    Vasios, G.5    Lane, W.S.6
  • 30
    • 0032886483 scopus 로고    scopus 로고
    • Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels
    • Yang S, Graham J, Kahn JW, Schwartz EA, Gerritsen ME. Functional roles for PECAM-1 (CD31) and VE-cadherin (CD144) in tube assembly and lumen formation in three-dimensional collagen gels. Am J Pathol 1999;155: 887-95.
    • (1999) Am J Pathol , vol.155 , pp. 887-895
    • Yang, S.1    Graham, J.2    Kahn, J.W.3    Schwartz, E.A.4    Gerritsen, M.E.5
  • 31
    • 84867676788 scopus 로고    scopus 로고
    • Comparative analysis of dynamic cell viability, migration and invasion assessments by novel real-time technology and classic endpoint assays
    • Limame R, Wouters A, Pauwels B, Fransen E, Peeters M, Lardon F, et al. Comparative analysis of dynamic cell viability, migration and invasion assessments by novel real-time technology and classic endpoint assays. PLoS One 2012;7:e46536.
    • (2012) PLoS One , vol.7
    • Limame, R.1    Wouters, A.2    Pauwels, B.3    Fransen, E.4    Peeters, M.5    Lardon, F.6
  • 32
  • 33
    • 80054778108 scopus 로고    scopus 로고
    • Targeted decorin gene therapy delivered with adeno-associated virus effectively retards corneal neovascularization in vivo
    • Mohan RR, Tovey JCK, Sharma A, Schultz GS, Cowden JW, Tandon A. Targeted decorin gene therapy delivered with adeno-associated virus effectively retards corneal neovascularization in vivo. PLoS One 2011;6:e26432.
    • (2011) PLoS One , vol.6
    • Mohan, R.R.1    Tovey, J.C.K.2    Sharma, A.3    Schultz, G.S.4    Cowden, J.W.5    Tandon, A.6
  • 34
    • 0034447622 scopus 로고    scopus 로고
    • Integrating the VEGF signals leading to actin-based motility in vascular endothelial cells
    • Rousseau S, Houle F, Huot J. Integrating the VEGF signals leading to actin-based motility in vascular endothelial cells. Trends Cardiovasc Med 2000;10: 321-7.
    • (2000) Trends Cardiovasc Med , vol.10 , pp. 321-327
    • Rousseau, S.1    Houle, F.2    Huot, J.3
  • 35
    • 33749028188 scopus 로고    scopus 로고
    • Vascular endothelial growth factor signaling pathways: Therapeutic perspective
    • Kowanetz M, Ferrara N. Vascular endothelial growth factor signaling pathways: therapeutic perspective. Clin Cancer Res 2006;12: 5018-22.
    • (2006) Clin Cancer Res , vol.12 , pp. 5018-5022
    • Kowanetz, M.1    Ferrara, N.2
  • 36
    • 34748863572 scopus 로고    scopus 로고
    • Mechanisms of integrin-vascular endothelial growth factor receptor crossactivation in angiogenesis
    • Mahabeleshwar GH, Feng W, Reddy K, Plow EF, Byzova TV. Mechanisms of integrin-vascular endothelial growth factor receptor crossactivation in angiogenesis. Circ Res 2007;10: 570-80.
    • (2007) Circ Res , vol.10 , pp. 570-580
    • Mahabeleshwar, G.H.1    Feng, W.2    Reddy, K.3    Plow, E.F.4    Byzova, T.V.5
  • 37
    • 0033558087 scopus 로고    scopus 로고
    • Role of avb3 integrin in the activation of vascular endothelial growth factor receptor-2
    • Soldi R, Mitola S, Strasly M, Defilippi P, Tarone G, Bussolino F. Role of avb3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J 1999;18: 882-92.
    • (1999) EMBO J , vol.18 , pp. 882-892
    • Soldi, R.1    Mitola, S.2    Strasly, M.3    Defilippi, P.4    Tarone, G.5    Bussolino, F.6
  • 38
    • 0035895711 scopus 로고    scopus 로고
    • Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family
    • Zachary I, Gliki G. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res 2001;49: 568-81.
    • (2001) Cardiovasc Res , vol.49 , pp. 568-581
    • Zachary, I.1    Gliki, G.2
  • 39
    • 84869777262 scopus 로고    scopus 로고
    • Vasculogenic mimicry of HT1080 tumor cells in vivo: Critical role of HIF-1a-neuropilin-1 axis
    • Misra RM, Bajaj MS, Kale VP. Vasculogenic mimicry of HT1080 tumor cells in vivo: critical role of HIF-1a-neuropilin-1 axis. PLoS One 2012;7: e50153.
    • (2012) PLoS One , vol.7
    • Misra, R.M.1    Bajaj, M.S.2    Kale, V.P.3
  • 40
    • 63849278644 scopus 로고    scopus 로고
    • The urokinase receptor as an entertainer of signal transduction
    • D'Alessio S, Blasi F. The urokinase receptor as an entertainer of signal transduction. Front Biosci 2009;14: 4575-87.
    • (2009) Front Biosci , vol.14 , pp. 4575-4587
    • D'Alessio, S.1    Blasi, F.2
  • 41
    • 77951269420 scopus 로고    scopus 로고
    • Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: Ameta-analysis of randomized controlled trials
    • Ranpura V, Hapani S, Chuang J, Wu S. Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: ameta-analysis of randomized controlled trials. Acta Oncol 2010;49: 287-97.
    • (2010) Acta Oncol , vol.49 , pp. 287-297
    • Ranpura, V.1    Hapani, S.2    Chuang, J.3    Wu, S.4
  • 42
    • 68549085490 scopus 로고    scopus 로고
    • Branching morphogenesis and antiangiogenesis candidates: Tip cells lead the way
    • Carmeliet P, De Smet F, Loges S, Mazzone M. Branching morphogenesis and antiangiogenesis candidates: tip cells lead the way. Nat Rev Clin Oncol 2009;6: 315-26.
    • (2009) Nat Rev Clin Oncol , vol.6 , pp. 315-326
    • Carmeliet, P.1    De Smet, F.2    Loges, S.3    Mazzone, M.4
  • 43
    • 80051720462 scopus 로고    scopus 로고
    • The urokinase receptor system, a key regulator at the intersection between inflammation, immunity, and coagulation
    • Del Rosso M, Margheri F, Serratì S, Chillà A, Laurenzana A, Fibbi G. The urokinase receptor system, a key regulator at the intersection between inflammation, immunity, and coagulation. Curr Pharm Des 2011;17: 1924-43.
    • (2011) Curr Pharm des , vol.17 , pp. 1924-1943
    • Del Rosso, M.1    Margheri, F.2    Serratì, S.3    Chill̀a, A.4    Laurenzana, A.5    Fibbi, G.6
  • 44
    • 77953684206 scopus 로고    scopus 로고
    • Are formyl peptide receptors novel targets for therapeutic intervention in ischaemia-reperfusion injury?
    • Gavins FNE. Are formyl peptide receptors novel targets for therapeutic intervention in ischaemia-reperfusion injury? Trends Pharmacol Sci 2010;31 266-76.
    • (2010) Trends Pharmacol Sci , vol.31 , pp. 266-276
    • Gavins, F.N.E.1
  • 45
    • 80051691520 scopus 로고    scopus 로고
    • The urokinase-type plasminogen activator and the generation of inhibitors of urokinase activity and signalling
    • Carriero MV, Stoppelli MP. The urokinase-type plasminogen activator and the generation of inhibitors of urokinase activity and signalling. Curr Pharm Des 2011;17: 1944-61.
    • (2011) Curr Pharm des , vol.17 , pp. 1944-1961
    • Carriero, M.V.1    Stoppelli, M.P.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.